Risk/benefit analysis for the use and approval of thrombolytic, antiarrhythmic, and hypolipidemic agents : proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988
Bibliographic Information
- Title
- "Risk/benefit analysis for the use and approval of thrombolytic, antiarrhythmic, and hypolipidemic agents : proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988"
- Statement of Responsibility
- edited by Joel Morganroth and E. Neil Moore
- Publisher
-
- Kluwer Academic Publishers
- Publication Year
-
- c1989
- Book size
- 24 cm
Search this Book/Journal
Notes
Includes bibliographical references
- Tweet
Details 詳細情報について
-
- CRID
- 1130282270902278272
-
- NII Book ID
- BA07429465
-
- ISBN
- 079230294X
-
- LCCN
- 89011044
-
- Web Site
- https://lccn.loc.gov/89011044
-
- Text Lang
- en
-
- Country Code
- us
-
- Title Language Code
- en
-
- Place of Publication
-
- Boston
-
- Subject
-
- LCSH: Fibrinolytic agents -- Effectiveness -- Congresses
- LCSH: Myocardial depressants -- Effectiveness -- Congresses
- LCSH: Antilipemic agents -- Effectiveness -- Congresses
- LCSH: Risk assessment -- Congresses
- MESH: Anti-Arrhythmia Agents -- therapeutic use -- congresses
- MESH: Antilipemic Agents -- therapeutic use -- congresses
- MESH: Fibrinolytic Agents -- therapeutic use -- congresses
-
- Data Source
-
- CiNii Books